These results were in agreement with Kübler et al. (8, 13), who have documented that MHC complex has a central role within the immunological integrity of the ovary, and the aberrant expression of HLA-class I and II molecules are supposed to contribute to cancer susceptibility or resistance to treatment. This evidence concerns the gene HLA-C and cancer.